Isobutylboronic Acidum CAS 84110-40-7 Puritas >99.0% (GC) Factory Bortezomib Intermedia High Munditia
Manufacturer Supple Quality, Commercial Productio
Nomen chemica: Isobutylboronic Acidum CAS: 84110-40-7
Nomen chemicum | Isobutylboronic Acidum |
Synonyma | 1-Isobutaneboronic Acidum;Acidum Isobutaneboronic;(2-Methylpropyl) acidum boronicum |
CAS Number | 84110-40-7 |
CATTUS Number | RF-PI1442 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C4H11BO2 |
M. Pondus | 101.94 |
Solubilitas | Solutum in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Puritas / Analysis Methodus | >99.0% (GC) |
Liquescens punctum | 108.0~112.0℃ |
Damnum in Siccatio | <0.50% |
Residere in Ignition | <0.50% |
Totalis immunditias | <1.00% |
Metalla gravia (ut Pb) | ≤20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical Intermedia;Bortezomib medium |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
Acidum Isobutylboronicum (CAS: 84110-40-7) notum est etiam ac Isobutaneboronic Acidum.Acidum Isobutylboricum synthesizare potentem et selectivam dipeptidylum boronicum acidum proteasome inhibitores adhibitum est, quae therapeutica promittunt se curaturos cancer et morbos inflammationes.Acidum Isobutylboronicum medium est Bortezomib (CAS: 179324-69-7).Bortezomib, acidum boronicum dipeptidylum modificatum, proteasome inhibitores therapeuticos ad carcinomata curanda adhibita est.Curatio relapsus multiplex myeloma et pallium lymphoma cella indicatur.Bortezomib, potens ubiquitin proteasome (26S) inhibitor (Ki=0.6 nM).